Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:20 AM
Ignite Modification Date:
2025-12-25 @ 2:20 AM
NCT ID:
NCT00473434
Eligibility Criteria:
Inclusion Criteria:
* Patients must satisfy the following criteria to be eligible for this study: patients with diagnoses of schizophrenia according to the DSM-IV criteria including newly diagnosed patients
* Out-patients or in-patients with expected discharge within 8 weeks
* Patients or their legally acceptable representatives must have signed an informed consent document indicating that they understand the purpose of and procedures required for the study and are willing to participate in the study.
Exclusion Criteria:
* Patients who meet any of the following criteria will be excluded from participating in the study: patients who are resistant to antipsychotic treatment
* Patients who have been on clozapine or long-acting injectable antipsychotic medication during the last 3 months
* Patients with CGl-S scores \> 6 or who who have been hospitalized for longer than 8 continuous weeks during the past 6 months
* Pregnant or breast-feeding females
* Patients with a history or current symptoms of tardive dyskinesia or neuroleptic malignant syndrome.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
65 Years
Study:
NCT00473434
Study Brief:
Protocol Section:
NCT00473434